Part of Previous Speakers:
|
Zhenping Zhu Executive Vice President, Biologics President and CEO, Kadmon China Kadmon Pharmaceuticals 朱祯平 全球生物制品副总,中国区总裁兼首席执行官 美国Kadmon制药 |
Prof.Patrick Baeuerle Senior Vice President, Chief Scientific Officer Micromet |
||
Klaus Wilgenbus, M.D. Corporate Senior Vice President, Global BD& Licensing/Strategy Boehringer Ingelheim |
Wei Zhang Director General, Department of Drug Registration State Food and Drug Administration |
||
Dr.Jin-San Yoo,Ph.D. President and CEO PharmAbcine |
Mingde XIA, Ph.D. Senior Director, COSAT Johnson & Johnson |
||
Prof. Yajun Guo President Chinese Engineering Research Center for Antibody Medicine |
Kathleen Metters Senior Vice President and Head of External Discovery and Preclinical Sciences Merck Research Laboratories |
||
Oliver Zhang Vice President, Antibody Drug Development GenScript |
Roger Perlmutter Ph.D Executive Vice President R&D Amgen |
||
Prof.Zhinan Chen Director, Cell Engineering Research Center, Department of Cell Biology The Fourth Military Medical University |
Andrew Buchanan Senior Team Leader and Scientist MedImmune |
||
Jian Gao Director of R&D Center North China Pharmaceutical Group Corporation |
James Zhao Partner Vivo Ventures |
||
download |
Choose your language |
Organized by |
Endorsers |
Presentation Sponsors |
Exhibition Sponsors |
Inertnational Media Partner |
special media partner |
Media |